Evidence map›Paper›PMID 27152617›Full record

ArticlePLoS genetics2016

Heat Shock Protein Beta-1 Modifies Anterior to Posterior Purkinje Cell Vulnerability in a Mouse Model of Niemann-Pick Type C Disease.

Chan Chung, Matthew J Elrick, James M Dell'Orco, Zhaohui S Qin, Shanker Kalyana-Sundaram, Arul M Chinnaiyan, Vikram G Shakkottai, Andrew P Lieberman

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alterations in Proteostasis Mechanisms in Niemann-Pick Type C Disease.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Article
  9. Sphingolipid metabolism governs Purkinje cell patterned degeneration inProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  10. Understanding and Treating Niemann-Pick Type C Disease: Models Matter.International journal of molecular sciences · 2020
    Review
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chan ChungDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.ORCID 0000-0003-0510-8996
Matthew J ElrickDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.ORCID 0000-0001-8565-7535
James M Dell'OrcoDepartment of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Zhaohui S QinDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia, United States of America.
Shanker Kalyana-SundaramDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Arul M ChinnaiyanDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Vikram G ShakkottaiDepartment of Neurology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
Andrew P LiebermanDepartment of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
University of Michigan · USEmory University · USHoward Hughes Medical Institute · US

Funding

Unraveling mechanisms of Niemann-Pick C neuropathology with mouse modelsR01NS063967 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LIEBERMAN, ANDREW P · 2009 to 2020
$4.4M
Identifying symptomatic and neuroprotective strategies for cerebellar ataxiaR01NS085054 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI SHAKKOTTAI, VIKRAM GOVINDARAJU · 2013 to 2023
$4.3M
Targeting physiologic changes as a route towards therapy for degenerative ataxiasK08NS072158 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAKKOTTAI, VIKRAM GOVINDARAJU · 2010 to 2014
$885k
Howard Hughes Medical InstituteNINDS NIH HHS K08 NS072158NINDS NIH HHS R01 NS063967NINDS NIH HHS R01 NS085054
6 · The paper itself

Abstract

Selective neuronal vulnerability is characteristic of most degenerative disorders of the CNS, yet mechanisms underlying this phenomenon remain poorly characterized. Many forms of cerebellar degeneration exhibit an anterior-to-posterior gradient of Purkinje cell loss including Niemann-Pick type C1 (NPC) disease, a lysosomal storage disorder characterized by progressive neurological deficits that often begin in childhood. Here, we sought to identify candidate genes underlying vulnerability of Purkinje cells in anterior cerebellar lobules using data freely available in the Allen Brain Atlas. This approach led to the identification of 16 candidate neuroprotective or susceptibility genes. We demonstrate that one candidate gene, heat shock protein beta-1 (HSPB1), promoted neuronal survival in cellular models of NPC disease through a mechanism that involved inhibition of apoptosis. Additionally, we show that over-expression of wild type HSPB1 or a phosphomimetic mutant in NPC mice slowed the progression of motor impairment and diminished cerebellar Purkinje cell loss. We confirmed the modulatory effect of Hspb1 on Purkinje cell degeneration in vivo, as knockdown by Hspb1 shRNA significantly enhanced neuron loss. These results suggest that strategies to promote HSPB1 activity may slow the rate of cerebellar degeneration in NPC disease and highlight the use of bioinformatics tools to uncover pathways leading to neuronal protection in neurodegenerative disorders.

Indexed as

AnimalsApoptosisCell SurvivalCerebellumDisease Models, AnimalHSP27 Heat-Shock ProteinsHumansMiceNerve DegenerationNeuronsNiemann-Pick Disease, Type CPurkinje CellsRNA, Small InterferingHSP27 Heat-Shock ProteinsRNA, Small Interfering

Identifiers

PMID27152617
PMCPMC4859571
OpenAlexW2346160609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.